Journal of the American Academy of Dermatology
Volume 63, Issue 1 , Pages 114-123 , July 2010

Factors affecting sleep quality in patients with psoriasis

  • Smitha Gowda, MD

      Affiliations

    • University of Maryland School of Medicine, Baltimore, Maryland
    • ,
  • Orin M. Goldblum, MD

      Affiliations

    • Abbott Laboratories, Abbott Park, Illinois
    • ,
  • W. Vaughn McCall, MD, MS

      Affiliations

    • Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina
    • ,
  • Steven R. Feldman, MD, PhD

      Affiliations

    • Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
    • Corresponding Author InformationCorrespondence to: Steven R. Feldman, MD, PhD, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1071.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding for manuscript development was provided by Abbott Laboratories. The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, LP.

 Disclosure: Dr Goldblum is an employee of Abbott Laboratories and owns Abbott stock. Dr McCall has served as an investigator for GlaxoSmithKline, Mini Mitter, the National Institutes of Health, Sanofi-Aventis, Sealy, Sepracor, and Somaxon, receiving research grants; has served as a consultant for AstraZeneca, Orexo AB, Sepracor, and Somaxon, receiving honoraria; and has served as a member of the speakers' bureaus for Sanofi-Aventis and Sepracor, receiving honoraria. Dr Feldman has served as an advisory board member, investigator, and speaker for Abbott Laboratories, Astellas, Galderma, Steifel, and Warner Chilcott, receiving grants and honoraria; has served on the advisory board for Photomedex, receiving stock options; has been an investigator and speaker for Amgen, Centocor, and Genentech, receiving grants and honoraria; and has served as an advisory board member and speaker for the National Psoriasis Foundation, receiving honoraria. Ms Gowda has no conflicts to declare.

 Reprints not available from the author.

PII: S0190-9622(09)00886-X

doi: 10.1016/j.jaad.2009.07.003

Journal of the American Academy of Dermatology
Volume 63, Issue 1 , Pages 114-123 , July 2010

Article Tools

* Image Usage & Resolution